SCHEMBL1929414

SCHEMBL1929414

COc1ccc(C2(c3ccc(OC)cc3)c3cc(N(c4ccccc4)c4ccccc4)ccc3-c3ccc(N(c4ccccc4)c4ccccc4)cc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.41
OPRL1 P41146 1/20 0.41
PDE4D Q08499 8/20 0.40
LRRK2 Q5S007 1/20 0.37
PDK2 Q15119 2/20 0.37
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
CA4 P22748 1/20 0.36
KMT2A Q03164 2/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
LTA4H P09960 1/20 0.36
SLC16A3 O15427 1/20 0.36
SLC16A1 P53985 1/20 0.36
ALOX5 P09917 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21031614 0.96 OPRM1 (0.42) OPRM1OPRL1PDE4DLRRK2PDK2
SCHEMBL17903090 0.93 OPRM1 (0.41) OPRM1OPRL1PDE4DPDK2KDM4E
SCHEMBL12376870 0.93 CA4 (0.39) OPRM1OPRL1LRRK2PDK2KDM4E
SCHEMBL16996132 0.92 PDK2 (0.41) OPRM1OPRL1PDE4DPDK2KDM4E
SCHEMBL16996425 0.91 PDK2 (0.40) OPRM1OPRL1PDE4DPDK2KDM4E
SCHEMBL21364231 0.91 PDK2 (0.40) OPRM1OPRL1PDE4DPDK2KDM4E
SCHEMBL12545359 0.90 PDE4D (0.39) OPRM1OPRL1PDE4DLTA4H
SCHEMBL22211030 0.90 PDK2 (0.44) OPRM1OPRL1PDE4DPDK2KDM4E
SCHEMBL17805080 0.90 PDK2 (0.45) OPRM1OPRL1PDE4DPDK2KDM4E
SCHEMBL22211047 0.89 PDK2 (0.44) OPRM1OPRL1PDE4DPDK2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7956350-B2 Crosslinkable substituted fluorene compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-06-07 US disclosed
US-7956350-B2 Crosslinkable substituted fluorene compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-06-07 US disclosed
US-7482490-B2 Amine compound having fluorene group as framework, process for producing the amine compound, and use of the amine compound TOSOH CORPORATION (JP) 2009-01-27 US disclosed
US-20080194878-A1 Amine Compound Having Fluorene Group as Framework, Process for Producing the Amine Compound, and Use of the Amine Compound TOSOH CORPORATION (JP) 2008-08-14 US disclosed
US-20070063191-A1 Crosslinkable substituted fluorene compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-03-22 US disclosed
US-20070063191-A1 Crosslinkable substituted fluorene compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-03-22 US disclosed
WO-2005049548-A1 CROSSLINKABLE SUBSTITUTED FLUORENE COMPOUNDS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194878-A1 Amine Compound Having Fluorene Group as Framework, Process for Producing the Amine Compound, and Use of the Amine Compound TAAR1, SLC18A1, ADRB2 OPRM1 91/4885OPRL1 38/4885PDE4D 3569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.